Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In Neuromuscular Disorders
Neuromuscular Disorders for November/December 2018
Global Burden of Motor Neuron Diseases Examined, Lancet Neurol; ePub 2018 Nov 5; Logroscino, et al
Neuromuscular Disorders for September/October 2018
FDA Approves Tiglutik for Treatment of ALS, ITF Pharma news release; 2018 Sep 6
Neuromuscular Disorders for July/August 2018
FDA Approves Xeomin for Excessive Drooling, Merz North America news release; 2018 Jul 3
Neuromuscular Disorders for May/June 2018
Integrated MRI and [11C]‐PBR28 PET Imaging in ALS, Ann Neurol; ePub 2018 May 8; Alshikho, et al
Neuromuscular Disorders for March/April 2018
FDA Approves Hizentra for CIDP Treatment, CSL Behring news release; 2018 Mar 16